stock
TNGX · Tango Therapeutics, Inc.
What Tango Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live TNGX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on TNGX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 168,610,367 as of 2026-08-04 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -253.4%
- Net
- -229.9%
Returns
- ROE
- -12.1%
- ROA
- -11.5%
Health
- Current ratio
- 50.8x
- Debt/equity
- —
Deep value
- NCAV
- $982.32M
- NCAV per share
- $5.83
- Price/NCAV
- Locked
- NNWC
- $296.21M
- NNWC per share
- $1.76
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $0 | —Gross profit: unreported by this company. | -$59.78M | -$55.34M | 10-Q filed 2026-08-11 |
| 2026-03-31 | $0 | —Gross profit: unreported by this company. | -$48.77M | -$45.51M | 10-Q filed 2026-08-11 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $0 | —Gross profit: unreported by this company. | -$41.86M | -$38.76M | DEF 14A filed 2026-04-17 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $53.81M | —Gross profit: unreported by this company. | $14.07M | $15.88M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $3.18M | —Gross profit: unreported by this company. | -$40.97M | -$38.85M | 10-Q filed 2026-08-11 |
| 2025-03-31 | $5.39M | —Gross profit: unreported by this company. | -$42.53M | -$39.88M | 10-Q filed 2026-08-11 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $4.12M | —Gross profit: unreported by this company. | -$40.91M | -$37.67M | DEF 14A filed 2026-04-17 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $11.61M | —Gross profit: unreported by this company. | -$32.88M | -$29.17M | 10-Q filed 2025-11-04 |
- Assets
- $1.07B
- Equity
- $1.02B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $62.38M | -$111.29M | -$101.60M | -$139.93M |
| 2024-12-31 | $42.07M | -$145.59M | -$130.30M | -$132.25M |
| 2023-12-31 | $36.53M | -$114.17M | -$101.70M | -$119.51M |
| 2022-12-31 | $24.86M | -$111.07M | -$108.18M | -$116.77M |
| 2021-12-31 | $37.04M | -$58.19M | -$58.23M | -$61.36M |
| 2020-12-31 | $7.66M | -$52.20M | -$51.97M | $68.97M |
Company filings
since Fri Nov 21 · 4 offering filings in 12 months · since Tue Aug 11
events
Other event
Other eventAug 118-KResults
ResultsAug 118-KExecutive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureAug 78-K/AExecutive or director change
Executive or director changeAug 68-KExecutive or director change
Executive or director changeJun 238-KMaterial agreement
Material agreementJun 108-K
5% owners ()
Nextech Crossover I GP S.a. r.l.
Stake update
TCG Crossover GP II, LLC
Stake update
THE GOLDMAN SACHS GROUP, INC.
Passive stake
Woodline Partners LP
Stake update
Farallon Capital Management, L.L.C.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Crystal Adam
President, R&D
Sale$660,796Oct 5, 5:36 PM ET
Newcomb Jessica
Principal Accounting Officer
Sale$198,613Sep 24, 7:41 PM ET
Crystal Adam
President, R&D
Sale$603,909Sep 3, 4:01 PM ET
Crystal Adam
President, R&D
Sale$735,517Aug 5, 4:01 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named TNGX, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about TNGX.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on TNGX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the TNGX board